Najat Khan

Insider Reports History

Entity
Individual
Location
41 S. Rio Grande Street, Salt Lake City, UT
Signature
/s/ Kyle Nelson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Najat Khan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief R&D Commercial Officer, Director Class A Common Stock 712K $5.16M $7.25 Feb 3, 2025 Direct
RECURSION PHARMACEUTICALS, INC. Chief R&D Commercial Officer, Director Stock Option (Right to Buy) 420K Feb 3, 2025 Direct

Insider Reports Filed by Najat Khan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Feb 3, 2025 4 -$20K 4 Feb 5, 2025 Chief R&D Commercial Officer, Director
RXRX RECURSION PHARMACEUTICALS, INC. Aug 1, 2024 2 $0 4 Aug 5, 2024 Chief R&D Commercial Officer, Director
RXRX RECURSION PHARMACEUTICALS, INC. Apr 16, 2024 0 $0 3 Apr 25, 2024 Director